Clinical trials: Chorioretinopathy
Central Serous Chorioretinopathy
Eplerenone for Central Serous Chorioretinopathy
The goal of the study is to examine the short-term effects and safety of a systemic anti-aldosterone medication, eplerenone, in a small group of patients with central serous chorioretinopathy (CSCR).
- Trial name
- NCT01822561
- Testing
- Eplerenone 50mg
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- Tufts Medical Center
Central Serous Chorioretinopathy
Two Patterns of Micropulse Laser in the Treatment of Chronic Central Serous Chorioretinopathy
Central serous chorioretinopathy (CSC) is a common eye disease mainly involving the macular area, causing central visual acuity loss.
- Trial name
- NCT05687422
- Testing
- 100μm laser spot diameter micropulse laser, 200μm laser spot diameter micropulse laser
- Volunteers
- 50 people
- Sponsor
- Beijing Hospital
Central Serous Chorioretinopathy
Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy
This study is a comparison of multifocal electroretinogram assessment between the laser treatment group and the photodynamic therapy group in chronic central serous chorioretinopathy.
- Trial name
- NCT00803517
- Where
- South Korea
- Volunteers
- 24 people
- Sponsor
- Samsung Medical Center
Central Serous Chorioretinopathy
Multimodal Imaging in Central Serous Chorioretinopathy
This study aims to assess the contribution of the multimodal imaging, combining a routine examination using Optical Coherence Tomography (OCT) with an imaging procedure using adaptive optics retinal camera.
- Trial name
- IMO (NCT02889185)
- Testing
- RTX1 IMAGIN EYE retinal camera
- Where
- France
- Volunteers
- 3 people
- Sponsor
- Centre Hospitalier Universitaire de Besancon
Acute Central Serous Retinopathy With Subretinal Fluid
Subthreshold Micropulse Laser Treatment of Acute Central Serous Chorioretinopathy
To evaluate the efficacy and safety of 532 nm green subthreshold micropulse laser (GSML) as a treatment for acute central serous chorioretinopathy (CSCR).
- Trial name
- NCT05447117
- Testing
- Micropulse laser
- Where
- Egypt
- Volunteers
- 42 people
- Sponsor
- Minia University
Central Serous Chorioretinopathy
Eplerenone for the Treatment of Central Serous Chorioretinopathy
To test the effect oral eplerenone versus placebo in patients with central serious chorioretinopathy .
- Trial name
- NCT01990677
- Testing
- 25mg Eplerenone
- Where
- 10 sites in United States
- Volunteers
- 108 people
- Sponsor
- Wills Eye
Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy
OCT in Rare Chorioretinal Diseases
This study will evaluate the total blood flow in the retina and choroid (structures in the back of the eye) by Doppler optical coherence tomography (OCT) and OCT angiography. Angiography is mapping of the blood vessels.
- Conditions
- Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia
- Trial name
- NCT02141308
- Where
- United States
- Volunteers
- 150 people
- Sponsor
- Oregon Health and Science University
Central Serous Chorioretinopathy
Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy
This is a prospective, multicentre, sham-controlled, participant- and assessor-masked superiority trial with two parallel treatment arms which aims to investigate the safety and efficacy of subthreshold nanosecond laser (SNL) in…
- Trial name
- NANO-C (NCT05570591)
- Testing
- 2RT subthreshold nanosecond laser - active
- Where
- 2 sites in Australia
- Volunteers
- 60 people
- Sponsor
- Nova Eye Medical Pty Ltd.
Chronic Central Serous Chorioretinopathy
Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population
The aim of the study is to determine the efficacy and safety of treatment with the drug eplerenone in patients with chronic central serous chorioretinopathy.
- Trial name
- NCT02462499
- Testing
- Inspra (eplerenone)
- Where
- Hungary
- Volunteers
- 28 people
- Sponsor
- Semmelweis University
Central Serous Chorioretinopathy
Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta Chment in Central Serous Chorioretinopathy
describing the influence of; combined Eplerenone, intravitreal Aflibercept, and topical Nepafenac; on serous foveal detachment in eyes with CSCR
- Trial name
- CSCR (NCT05847049)
- Testing
- Eplerenone , Intravitreal Aflibercept and Topical nepafenac therapy
- Where
- Egypt
- Volunteers
- 16 people
- Sponsor
- Dar El Oyoun Hospital
Central Serous Chorioretinopathy
A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
Central serous chorioretinopathy (CSC) is supposedly the fourth most common non-surgical retinopathy after age-related macular degeneration, diabetic retinopathy and branch retinal vein occlusion.
- Trial name
- NCT02215330
- Testing
- Eplerenone, Maltodextrin
- Where
- Austria
- Volunteers
- 60 people
- Sponsor
- Prim. Prof. Dr. Oliver Findl, MBA
Anterior Uveitis (AU), Birdshot Chorioretinitis
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method of counting and categorizing the various types of…
- Conditions
- Anterior Uveitis (AU), Birdshot Chorioretinitis, Behcet Disease, Herpes Simplex Virus
- Trial name
- NCT07065747
- Where
- United States
- Volunteers
- 125 people, healthy volunteers welcome
- Sponsor
- Oregon Health and Science University
Central Serous Retinopathy (CSR)
Eye Patch Therapy for Central Serous Retinopathy (CSR)
First, this study will investigate the viability of 24-hour eye patching as a potential treatment modality for CSR. Second, this study will assess a potential physiologic explanation for CSR, namely if inhibition of photic…
- Trial name
- NCT02036632
- Testing
- Eye Patching
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Washington University School of Medicine
Central Serous Chorioretinopathy
Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)
The purpose of this study is to evaluate the clinical efficacy of an initial subthreshold retinal micropulselasercoagulation versus a single intravitreal 1.5mg bevacizumab injection in central serous choriretinopathy, as the…
- Trial name
- NCT00802906
- Testing
- subthreshold micropulselaser, bevacizumab
- Where
- Germany
- Volunteers
- 12 people
- Sponsor
- Johann Wolfgang Goethe University Hospital